Trials by Condition
Showing 21 - 31 of 31 trials – Showing only trials currently accepting patients
-
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
Stanford is currently accepting patients for this trial. -
CIBMTR Research Database
Stanford is currently accepting patients for this trial. -
CTL019 Out of Specification MAP for ALL or DLBCL Patients
Stanford is currently accepting patients for this trial. -
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Stanford is currently accepting patients for this trial. -
Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant
Stanford is currently accepting patients for this trial. -
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Stanford is currently accepting patients for this trial. -
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Stanford is currently accepting patients for this trial. -
A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Stanford is currently accepting patients for this trial. -
A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)
Stanford is currently accepting patients for this trial. -
A Study of SNDX-5613 in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Stanford is currently accepting patients for this trial. -
A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors
Stanford is currently accepting patients for this trial.